Insider Selling: Globe Life (NYSE:GL) Director Sells 1,750 Shares of Stock

Globe Life Inc. (NYSE:GL) Director Mark Blinn sold 1,750 shares of the firm’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $147.91, for a total transaction of $258,842.50. Following the completion of the sale, the director owned 3,372 shares of the company’s stock, valued at $498,752.52. The trade was a 34.17% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.

Globe Life Trading Up 0.4%

GL stock traded up $0.62 during midday trading on Tuesday, reaching $142.04. The stock had a trading volume of 425,195 shares, compared to its average volume of 530,763. The firm has a market cap of $11.31 billion, a price-to-earnings ratio of 9.73 and a beta of 0.47. Globe Life Inc. has a twelve month low of $109.38 and a twelve month high of $152.71. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. The business has a fifty day simple moving average of $139.55 and a two-hundred day simple moving average of $138.24.

Globe Life (NYSE:GL) last issued its earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.44 by ($0.05). The business had revenue of $1.52 billion during the quarter, compared to the consensus estimate of $1.53 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The firm’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period last year, the business posted $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, research analysts expect that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently issued reports on GL shares. Morgan Stanley restated an “overweight” rating and issued a $176.00 price target on shares of Globe Life in a research report on Monday, December 15th. Evercore lowered Globe Life from an “outperform” rating to an “in-line” rating and set a $155.00 target price on the stock. in a research note on Tuesday, January 6th. JPMorgan Chase & Co. boosted their target price on Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. TD Cowen reiterated a “buy” rating on shares of Globe Life in a research report on Thursday, December 11th. Finally, Wells Fargo & Company reduced their price objective on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research note on Friday, October 24th. Seven equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Globe Life currently has an average rating of “Moderate Buy” and a consensus price target of $171.00.

Hedge Funds Weigh In On Globe Life

Several institutional investors have recently modified their holdings of the business. Transcend Capital Advisors LLC raised its holdings in Globe Life by 3.9% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock worth $317,000 after buying an additional 84 shares during the period. Natural Investments LLC raised its holdings in shares of Globe Life by 2.6% during the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock worth $482,000 after acquiring an additional 87 shares during the period. Intech Investment Management LLC lifted its position in Globe Life by 0.8% in the 2nd quarter. Intech Investment Management LLC now owns 11,572 shares of the company’s stock valued at $1,438,000 after acquiring an additional 95 shares in the last quarter. CX Institutional lifted its position in Globe Life by 5.6% in the 3rd quarter. CX Institutional now owns 1,805 shares of the company’s stock valued at $258,000 after acquiring an additional 96 shares in the last quarter. Finally, Laird Norton Wetherby Wealth Management LLC boosted its stake in Globe Life by 2.2% in the 3rd quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,518 shares of the company’s stock worth $646,000 after purchasing an additional 99 shares during the period. Institutional investors own 81.61% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.